05/13/2025
8:08 PM | 3i, LP (Filed by)
BriaCell Therapeutics (Subject)
BriaCell Therapeutics Corp. (Subject)
| Form SCHEDULE 13G/A | |
05/01/2025
9:01 AM | BriaCell Therapeutics (Subject)
BriaCell Therapeutics Corp. (Subject)
CVI Investments, Inc. (Filed by)
| Form SCHEDULE 13G | |
04/28/2025
3:15 PM | BriaCell Therapeutics (Filer)
BriaCell Therapeutics Corp. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/28/2025
8:06 AM | BriaCell Therapeutics (Filer)
BriaCell Therapeutics Corp. (Filer)
| Form 424B4 | |
04/28/2025
8:07 AM | BriaCell Therapeutics (Filer)
BriaCell Therapeutics Corp. (Filer)
| Form 424B4 | |
04/24/2025
11:15 PM | BriaCell Therapeutics (Filer)
BriaCell Therapeutics Corp. (Filer)
| Form EFFECT | |
04/24/2025
4:11 PM | BriaCell Therapeutics (Filer)
BriaCell Therapeutics Corp. (Filer)
| Form S-1MEF | |
04/24/2025
3:41 PM | BriaCell Therapeutics (Filer)
BriaCell Therapeutics Corp. (Filer)
| Form CERT | |
04/24/2025
2:46 PM | BriaCell Therapeutics (Filer)
BriaCell Therapeutics Corp. (Filer)
| Form 8-A12B | |
04/23/2025
3:51 PM | BriaCell Therapeutics (Filer)
BriaCell Therapeutics Corp. (Filer)
| Form S-1/A | |
04/22/2025
3:26 PM | BriaCell Therapeutics (Subject)
BriaCell Therapeutics Corp. (Subject)
| Form FWP | |
Get the Latest News and Ratings for BCTX and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for BriaCell Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
02/10/2025
8:02 PM | 3i, LP (Filed by)
BriaCell Therapeutics (Subject)
BriaCell Therapeutics Corp. (Subject)
| Form SCHEDULE 13G | |
02/06/2025
3:30 PM | BriaCell Therapeutics (Filer)
BriaCell Therapeutics Corp. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/05/2025
4:02 PM | BriaCell Therapeutics (Filer)
BriaCell Therapeutics Corp. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/04/2025
3:05 PM | BriaCell Therapeutics (Filer)
BriaCell Therapeutics Corp. (Filer)
| Form 424B5 | |
02/03/2025
3:37 PM | BriaCell Therapeutics (Filer)
BriaCell Therapeutics Corp. (Filer)
| Form 424B5 | |
12/17/2024
3:05 PM | BriaCell Therapeutics (Filer)
BriaCell Therapeutics Corp. (Filer)
| Form DEF 14A | |
12/13/2024
3:15 PM | BriaCell Therapeutics (Filer)
BriaCell Therapeutics Corp. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/12/2024
4:27 PM | BriaCell Therapeutics (Filer)
BriaCell Therapeutics Corp. (Filer)
| Form 424B5 | |
12/12/2024
5:06 AM | BriaCell Therapeutics (Subject)
BriaCell Therapeutics Corp. (Subject)
L5 Capital Inc. (Filed by)
| Form SC 13D/A | |
12/11/2024
4:21 PM | BriaCell Therapeutics (Filer)
BriaCell Therapeutics Corp. (Filer)
| Form 424B5 | |
12/10/2024
5:06 AM | BriaCell Therapeutics (Subject)
BriaCell Therapeutics Corp. (Subject)
L5 Capital Inc. (Filed by)
| Form SC 13D/A | |
12/05/2024
6:45 AM | BriaCell Therapeutics (Subject)
BriaCell Therapeutics Corp. (Subject)
L5 Capital Inc. (Filed by)
| Form SC 13D/A | |
11/14/2024
11:17 AM | BriaCell Therapeutics (Subject)
BriaCell Therapeutics Corp. (Subject)
CVI Investments, Inc. (Filed by)
| Form SC 13G/A | |
11/01/2024
3:05 PM | BriaCell Therapeutics (Filer)
BriaCell Therapeutics Corp. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/02/2024
9:12 AM | BriaCell Therapeutics (Filer)
BriaCell Therapeutics Corp. (Filer)
| Form 424B5 | |
10/01/2024
3:02 PM | BriaCell Therapeutics (Filer)
BriaCell Therapeutics Corp. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/16/2024
9:22 AM | BriaCell Therapeutics (Subject)
BriaCell Therapeutics Corp. (Subject)
CVI Investments, Inc. (Filed by)
| Form SC 13G | |
09/12/2024
3:25 PM | BriaCell Therapeutics (Filer)
BriaCell Therapeutics Corp. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/11/2024
7:50 AM | BriaCell Therapeutics (Filer)
BriaCell Therapeutics Corp. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/11/2024
7:50 AM | BriaCell Therapeutics (Filer)
BriaCell Therapeutics Corp. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/23/2024
4:00 PM | BriaCell Therapeutics (Filer)
BriaCell Therapeutics Corp. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/18/2024
3:30 PM | BriaCell Therapeutics (Filer)
BriaCell Therapeutics Corp. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/05/2024
3:10 PM | BriaCell Therapeutics (Filer)
BriaCell Therapeutics Corp. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/24/2024
7:58 AM | BriaCell Therapeutics (Subject)
BriaCell Therapeutics Corp. (Subject)
L5 Capital Inc. (Filed by)
| Form SC 13D/A | |
